Keros Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$15.65(as of Sep 10, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Keros Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$15.65
Ticker SymbolKROS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees148
CountyUSA
Market Cap$638.1M
EBIDTA1.7M
10-Day Moving Average15.54
P/E Ratio33.86
20-Day Moving Average15.10
Forward P/E Ratio48.78
50-Day Moving Average14.49
Earnings per Share0.32
200-Day Moving Average17.00
Profit Margin-168.96%
RSI59.98
Shares Outstanding40.6M
ATR0.56
52-Week High72.37
Volume287,751
52-Week Low9.12
Most Recent Support Level15.25
Book Value706.7M
Most Recent Resistance Level16.00
P/B Ratio0.90
Upper Keltner16.35
P/S Ratio2.73
Lower Keltner13.84
Debt-to-Equity Ratio16.35
Next Earnings Date10/30/2025
Cash Surplus655.5M
Next Ex-Dividend DateUnknown

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-012, which is in Phase II clinical trial to treat pulmonary arterial hypertension and cardiovascular disorders; and KER-065 that is in Phase I clinical trial for the treatment neuromuscular diseases. The company has collaboration and license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

Keros Therapeutics Inc In Our Stock Scanner

As of Sep 11, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.